Hamilton Ventilator Recall Issued Over Short Circuit, Capacitor Leak Risks
The FDA warns that the recalled Hamilton ventilators may fail and stop providing potentially life-saving air therapy support to patients due to design problem.
The FDA warns that the recalled Hamilton ventilators may fail and stop providing potentially life-saving air therapy support to patients due to design problem.
At least 80 complaints involving ventilator failures have been reported in relation to faulty software that prompted a recall for about 12,429 Hamilton ventilators
The FDA warns that the recalled Draeger Carina ventilators contain toxic sound abatement foam which could put patients at an increased risk of cancer and death.
This is the latest in a string of Philips CPAP and ventilators recalls over the last several years, with most involving toxic sound abatement foam.
Recalled Dräger ventilators contain PE-PUR sound insulation foam that could release toxic gases, causing similar problems linked to a massive Philips CPAP recall issued more than two years ago.
An air flow sensor in the recalled Philips Trilogy Evo, Garbin Evo, and Aeris EVO ventilators may not detect the build-up of debris in the devices, which could lead to low blood oxygen, serious injuries and death.
At least four injuries and one death have been linked to the recalled Ballard Access infant ventilator systems.
Supposedly repaired Trilogy and Garbin Plus Ventilators may experience silicone foam adhesive failure, which could lead to airpaths being blocked, putting ventilator patients at risk.
The FDA warns some reworked Trilogy 100 and 200 Ventilators still have toxic sound abatement foam residue, and the adhesive on the replacement foam may fail, blocking the ventilator.
It is the latest stumble in the company's efforts to remediate and replace recalled Philips CPAP devices and ventilators